EpCAM: Structure and function in health and disease

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 8, 2013, Pages 1989-2001

  Schnell, Ulrike ^a   Cirulli, Vincenzo ^b   Giepmans, Ben N G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer; Cell cell contact; Congenital tufting enteropathy; Epithelial Cell Adhesion Molecule (EpCAM); Regulated intramembrane proteolysis; Tetraspanin enriched microdomains

Indexed keywords

CATUMAXOMAB; EPITHELIAL CELL ADHESION MOLECULE; MEMBRANE ANTIGEN; TETRASPANIN; TROPHOBLAST CELL SURFACE ANTIGEN 2; UNCLASSIFIED DRUG;

BREAST CANCER; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONGENITAL TUFTING ENTEROPATHY; DEVELOPMENT; DISEASE MODEL; EMBRYONIC STEM CELL; ENTEROPATHY; GALLBLADDER CARCINOMA; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; KIDNEY CARCINOMA; MALIGNANT ASCITES; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THYROID CARCINOMA; UROGENITAL TRACT TUMOR;

ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL MEMBRANE; HUMANS; MICE; NEOPLASMS;

MUS;

EID: 84878005309     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.04.018     Document Type: Review

References (158)

1. S.E.L. Craig, and S.M. Brady-Kalnay Cancer cells cut homophilic cell adhesion molecules and run Cancer Res. 71 2011 303 309
2. F. Fagotto, and B.M. Gumbiner Cell contact-dependent signaling Dev. Biol. 180 1996 445 454 (Pubitemid 27037353)
3. M.M.P. Zegers, M.-A. Forget, J. Chernoff, K.E. Mostov, M.B. a ter Beest, and S.H. Hansen Pak1 and PIX regulate contact inhibition during epithelial wound healing EMBO J. 22 2003 4155 4165 (Pubitemid 37021744)
4. Y. Takai, J. Miyoshi, W. Ikeda, and H. Ogita Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation Nat. Rev. Mol. Cell Biol. 9 2008 603 615 (Pubitemid 352032927)
5. M. Trzpis, P.M.J. McLaughlin, L.M.F.H. de Leij, and M.C. Harmsen Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule Am. J. Pathol. 171 2007 386 395 (Pubitemid 47344671)
6. G. Köhler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
7. M. Herlyn, Z. Steplewski, D. Herlyn, and H. Koprowski Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies Proc. Natl. Acad. Sci. U.S.A. 76 1979 1438 1442 (Pubitemid 9136880)
8. P.A. Baeuerle, and O. Gires EpCAM (CD326) finding its role in cancer Br. J. Cancer 96 2007 417 423 (Pubitemid 46215211)
9. M. Münz, A. Murr, M. Kvesic, D. Rau, S. Mangold, S. Pflanz, J. Lumsden, J. Volkland, J. Fagerberg, G. Riethmüller, D. Rüttinger, P. Kufer, P.A. Baeuerle, and T. Raum Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies Cancer Cell Int. 10 2010 44
10. G.S. Spizzo, P.O. Brist, C.E. Nsinger, I.T. Heurl, and D.U. Martina Prognostic significance of Ep-CAM and Her-2/ neu overexpression in invasive breast cancer Int. J. Cancer 98 2002 883 888
11. G. Spizzo, P. Went, S. Dirnhofer, P. Obrist, R. Simon, H. Spichtin, R. Maurer, U. Metzger, B. von Castelberg, R. Bart, S. Stopatschinskaya, O.R. Köchli, P. Haas, F. Mross, M. Zuber, H. Dietrich, S. Bischoff, M. Mirlacher, G. Sauter, and G. Gastl High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer Breast Cancer Res. Treat. 86 2004 207 213 (Pubitemid 39070963)
12. M. Varga, P. Obrist, and S. Schneeberger Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival Clin. Cancer Res. 10 2004 3131 3136 (Pubitemid 38619694)
13. A. Brunner, G. Schaefer, L. Veits, B. Brunner, M. Prelog, and C. Ensinger EpCAM overexpression is associated with high-grade urothelial carcinoma in the renal pelvis Anticancer Res. 28 2008 125 128 (Pubitemid 351362890)
14. P. Scheunemann, N.H. Stoecklein, A. Rehders, M. Bidde, S. Metz, M. Peiper, C.F. Eisenberger, J. Schulte Am Esch, W.T. Knoefel, and S.B. Hosch Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma, Langenbecks Arch. Surg. 393 2008 359 365 (Pubitemid 351661252)
15. D. Fong, M. Steurer, P. Obrist, V. Barbieri, R. Margreiter, A. Amberger, K. Laimer, G. Gastl, A. Tzankov, and G. Spizzo Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance J. Clin. Pathol. 61 2008 31 35 (Pubitemid 351158222)
16. M. Sivagnanam, J.L. Mueller, H. Lee, Z. Chen, S.F. Nelson, D. Turner, S.H. Zlotkin, P.B. Pencharz, B.-Y. Ngan, O. Libiger, N.J. Schork, J.E. Lavine, S. Taylor, R.O. Newbury, R.D. Kolodner, and H.M. Hoffman Identification of EpCAM as the gene for congenital tufting enteropathy Gastroenterology 135 2008 429 437
17. S.V. Litvinov, M.P. Velders, H.A. Bakker, G.J. Fleuren, and S.O. Warnaar Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule J. Cell Biol. 125 1994 437 446 (Pubitemid 24135956)
18. S.V. Litvinov, M. Balzar, M.J. Winter, H.A. Bakker, I.H. Briaire-de Bruijn, F. Prins, G.J. Fleuren, and S.O. Warnaar Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins J. Cell Biol. 139 1997 1337 1348 (Pubitemid 27523219)
19. M. Balzar, M.J. Winter, C.J. de Boer, and S.V. Litvinov The biology of the 17-1A antigen (Ep-CAM) J. Mol. Med. 77 1999 699 712
20. M. Münz, C. Kieu, B. Mack, B. Schmitt, R. Zeidler, and O. Gires The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation Oncogene 23 2004 5748 5758 (Pubitemid 39093020)
21. M. Lipinski, D.R. Parks, R.V. Rouse, and L.A. Herzenberg Human trophoblast cell-surface antigens defined by monoclonal antibodies Proc. Natl. Acad. Sci. U.S.A. 78 1981 5147 5150 (Pubitemid 12229690)
22. M.J. Mattes, J.G. Cairncross, L.J. Old, and K.O. Lloyd Monoclonal antibodies to three widely distributed human cell surface antigens Hybridoma 2 1983 253 264 (Pubitemid 14176974)
23. N. Varki, R. Reisfeld, and L. Walker Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies Cancer Res. 44 1984 681 687 (Pubitemid 14184605)
24. D.P. Edwards, K.T. Grzyb, L.G. Dressler, L.G. Dressier, R.E. Mansel, D.T. Zava, G.W. Sledge, and W.L. Mcguire Monoclonal antibody identification and characterization of a Mr 43, 000 membrane glycoprotein associated with human breast cancer Cancer Res. 46 1986 1306 1317 (Pubitemid 16048272)
25. G. Moldenhauer, F. Momburg, P. Möller, R. Schwartz, and G.J. Hämmerling Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker Br. J. Cancer 56 1987 714 721 (Pubitemid 18048339)
26. I. Thampoe, J. Ng, and K. Lloyd Biochemical analysis of a human epithelial surface antigen: differential cell expression and processing Arch. Biochem. Biophys. 267 1988 342 352 (Pubitemid 19001035)
27. J. Strnad, A.E. Hamilton, L.S. Beavers, G.C. Gamboa, L.D. Apelgren, L.D. Taber, J.R. Sportsman, T.F. Bumol, J.D. Sharp, and R.A. Gadski Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA Cancer Res. 49 1989 314 317 (Pubitemid 19049519)
28. H. Durbin, N. Rodrigues, and W.F. Bodmer Further characterization, isolation and identification of the epithelial cell-surface antigen defined by monoclonal antibody aua1 Int. J. Cancer 45 1990 562 565 (Pubitemid 20087209)
29. C. Klein, B. Hartmann, M. Schön, L. Weber, and S. Alberti Expression of 38-kD cell-surface glycoprotein in transformed keratinocyte cell lines, basal cell carcinomas, and epithelial germs J. Invest. Dermatol. 95 1990 74 82 (Pubitemid 20219447)
30. U. Latza, G. Niedobitek, R. Schwarting, H. Nekarda, and H. Stein Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial J. Clin. Pathol. 43 1990 213 219 (Pubitemid 20087572)
31. A.T. Myklebust, K. Beiske, A. Pharo, C.D. Davies, S. Aamdal, and O. Fodstad Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis Br. J. Cancer Suppl. 14 1991 49 53
32. A.J. Linnenbach, B.A. Seng, S. Wu, S. Robbins, M. Scollon, J.J. Pyrc, T. Druck, and K. Huebner Retroposition in a family of carcinoma-associated antigen genes Mol. Cell. Biol. 13 1993 1507 1515 (Pubitemid 23068088)
33. R. Watanabe, H. Johzaki, H. Iwasaki, M. Kikuchi, and S. Ikeda A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma Cancer 71 1993 2439 2447 (Pubitemid 23100474)
34. W. Helfrich, P.W. Koning, T.H. The, and L. De Leij Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopes Int. J. Cancer Suppl. 8 1994 64 69 (Pubitemid 24188961)
35. L. De Leij, W. Helfrich, R. Stein, and M.J. Mattes SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2 Int. J. Cancer 8 1994 60 63 (Pubitemid 24188960)
36. S.V. Litvinov, H.A. Bakker, M.M. Gourevitch, M.P. Velders, and S.O. Warnaar Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion Cell Adhes. Commun. 2 1994 417 428 (Pubitemid 24351019)
37. E. Ripani, A. Sacchetti, D. Corda, and S. Alberti Human Trop-2 is a tumor-associated calcium signal transducer Int. J. Cancer 76 1998 671 676 (Pubitemid 28243939)
38. H. Abe, M. Kuroki, T. Imakiire, Y. Yamauchi, H. Yamada, F. Arakawa, and M. Kuroki Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients J. Immunol. Methods 270 2002 227 233
39. P. Went, M. Vasei, L. Bubendorf, L. Terracciano, L. Tornillo, U. Riede, J. Kononen, R. Simon, G. Sauter, and P.A. Baeuerle Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers Br. J. Cancer 94 2006 128 135 (Pubitemid 43088552)
40. A. Farr, A. Nelson, J. Truex, and S. Hosier Epithelial heterogeneity in the murine thymus: a cell surface glycoprotein expressed by subcapsular and medullary epithelium J. Histochem. Cytochem. 39 1991 645 653
41. S. Szala, Y. Kasai, Z. Steplewski, U. Rodeck, H. Koprowski, and A.J. Linnenbach Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens Proc. Natl. Acad. Sci. U.S.A. 87 1990 6833 6837
42. A.J. Linnenbach, J. Wojcierowski, S. Wu, J.J. Pyrc, A.H. Ross, B. Dietzschold, D. Speicher, and H. Koprowski Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733 Proc. Natl. Acad. Sci. U.S.A. 86 1989 27 31 (Pubitemid 19036329)
43. J.M. Chong, and D.W. Speicher Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM) J. Biol. Chem. 276 2001 5804 5813
44. B. Simon, D.K. Podolsky, G. Moldenhauer, K.J. Isselbacher, S. Gattoni-Celli, and S.J. Brand Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein Proc. Natl. Acad. Sci. U.S.A. 87 1990 2755 2759
45. F. Molina, M. Bouanani, B. Pau, and C. Granier Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families Eur. J. Biochem. 240 1996 125 133 (Pubitemid 26276763)
46. P. Meh, M. Pavsic, V. Turk, A. Baici, and B. Lenarcic Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L Biol. Chem. 386 2005 75 83 (Pubitemid 40361454)
47. V. Turk, V. Stoka, O. Vasiljeva, M. Renko, T. Sun, B. Turk, and D. Turk Cysteine cathepsins: from structure, function and regulation to new frontiers Biochim. Biophys. Acta 1824 2012 68 88
48. M.P. Schön, M. Schön, M.J. Mattes, R. Stein, L. Weber, S. Alberti, and C.E. Klein Biochemical and immunological characterization of the human carcinoma-associated antigen MH 99/KS 1/4 Int. J. Cancer 55 1993 988 995 (Pubitemid 24005346)
49. M. Munz, K. Fellinger, T. Hofmann, B. Schmitt, and O. Gires Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM Front. Biosci. 13 2008 5195 5201 (Pubitemid 351599669)
50. R.S. Haltiwanger Regulation of signal transduction pathways in development by glycosylation Curr. Opin. Struct. Biol. 12 2002 593 598 (Pubitemid 35449066)
51. S. Hakomori Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism Cancer Res. 56 1996 5309 5318 (Pubitemid 27011703)
52. N. Haines, and K.D. Irvine Glycosylation regulates Notch signalling Nat. Rev. Mol. Cell Biol. 4 2003 786 797 (Pubitemid 37229375)
53. S.S. Pinho, R. Seruca, F. Gärtner, Y. Yamaguchi, J. Gu, N. Taniguchi, and C.A. Reis Modulation of E-cadherin function and dysfunction by N-glycosylation Cell. Mol. Life Sci. 68 2011 1011 1020
54. C. Pauli, M. Münz, C. Kieu, B. Mack, P. Breinl, B. Wollenberg, S. Lang, R. Zeidler, and O. Gires Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas Cancer Lett. 193 2003 25 32 (Pubitemid 36416612)
55. T. Nübel, J. Preobraschenski, H. Tuncay, T. Weiss, S. Kuhn, M. Ladwein, L. Langbein, and M. Zöller Claudin-7 regulates EpCAM-mediated functions in tumor progression Mol. Cancer Res. 7 2009 285 299
56. M. Balzar, H.A. Bakker, I.H. BriairedeBruijn, G.J. Fleuren, S.O. Warnaar, and S.V. Litvinov Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule Mol. Cell Biol 18 1998 4833 4843 (Pubitemid 28343067)
57. M. Balzar, I.H. Briaire-de Bruijn, H.A.M. Rees-Bakker, F.A. Prins, W. Helfrich, L. De Leij, G. Riethmüller, S. Alberti, S.O. Warnaar, G.J. Fleuren, and Litvinov Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions Mol. Cell. Biol. 21 2001 2570 2580 (Pubitemid 32222108)
58. U. Schnell, J. Kuipers, and B.N.G. Giepmans EpCAM proteolysis: new fragments with distinct functions? Biosci. Rep. 33 2013 e00030 10.1042/BSR20120128 (ahead of print)
59. A. Basu, D.M. Goldenberg, and R. Stein The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303 Int. J. Cancer 62 1995 472 479
60. R. Cubas, M. Li, C. Chen, and Q. Yao Trop2: a possible therapeutic target for late stage epithelial carcinomas Biochim. Biophys. Acta 1796 2009 309 314
61. M. Balzar, F.A. Prins, H.A. Bakker, G.J. Fleuren, S.O. Warnaar, and S.V. Litvinov The structural analysis of adhesions mediated by Ep-CAM Exp. Cell Res. 246 1999 108 121 (Pubitemid 29393751)
62. C.J. Wu, P. Mannan, M. Lu, and M.C. Udey Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions J. Biol. Chem. 2013 10.1074/jbc.M113.457499 (Epub ahead of print)
63. M.R. Gaiser, T. Lämmermann, X. Feng, B.Z. Igyarto, D.H. Kaplan, L. Tessarollo, R.N. Germain, and M.C. Udey Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo Proc. Natl. Acad. Sci. U.S.A. 109 2012 E889 E897
64. B.M. Gumbiner Cell adhesion: the molecular basis of tissue architecture and morphogenesis Cell 84 1996 345 357 (Pubitemid 26058560)
65. R. Del Buono, and M. Pignatelli The role of the E-cadherin complex in gastrointestinal cell differentiation Cell Prolif. 32 1999 79 84 (Pubitemid 29488051)
66. G. Handschuh, S. Candidus, B. Luber, U. Reich, C. Schott, S. Oswald, H. Becke, P. Hutzler, W. Birchmeier, H. Höfler, and K.F. Becker Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility Oncogene 18 1999 4301 4312 (Pubitemid 29392371)
67. G. Christofori, and H. Semb The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene Trends Biochem. Sci. 24 1999 73 76 (Pubitemid 29346577)
68. K. Vleminckx, L. Vakaet, M. Mareel, W. Fiers, and F. van Roy Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell 66 1991 107 119 (Pubitemid 121001351)
69. B. Mayer, J. Johnson, F. Leitl, and K. Jauch E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration Cancer Res. 53 1993 1690 1695 (Pubitemid 23113253)
70. A.K. Perl, P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori A causal role for E-cadherin in the transition from adenoma to carcinoma Nature 392 1998 190 193 (Pubitemid 28162793)
71. M.J. Winter, I.D. Nagtegaal, J.H.J.M. van Krieken, and S.V. Litvinov The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology Am. J. Pathol. 163 2003 2139 2148 (Pubitemid 37466457)
72. M. Perrais, X. Chen, and M. Perez-Moreno E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions Mol. Biol. Cell 18 2007 2013 2025 (Pubitemid 46911354)
73. Z. Lei, T. Maeda, A. Tamura, T. Nakamura, Y. Yamazaki, H. Shiratori, K. Yashiro, S. Tsukita, and H. Hamada EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins Dev. Biol. 371 2012 136 145
74. D. Maetzel, S. Denzel, B. Mack, M. Canis, P. Went, M. Benk, C. Kieu, P. Papior, P.A. Baeuerle, M. Münz, and O. Gires Nuclear signalling by tumour-associated antigen EpCAM Nat. Cell Biol. 11 2009 162 171
75. W.A. Osta, Y. Chen, K. Mikhitarian, M. Mitas, M. Salem, Y.A. Hannun, D.J. Cole, and W.E. Gillanders EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy Cancer Res. 64 2004 5818 5824 (Pubitemid 39095582)
76. D. Wenqi, W. Li, C. Shanshan, C. Bei, Z. Yafei, B. Feihu, L. Jie, and F. Daiming EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer J. Cancer Res. Clin. Oncol. 135 2009 1277 1285
77. A. Chaves-Pérez, B. Mack, D. Maetzel, H. Kremling, C. Eggert, U. Harréus, and O. Gires EpCAM regulates cell cycle progression via control of cyclin D1 expression Oncogene 2012 1 10
78. M. Münz, R. Zeidler, and O. Gires The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP Cancer Lett. 225 2005 151 157 (Pubitemid 40732778)
79. M.S. Brown, J. Ye, R.B. Rawson, and J.L. Goldstein Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans Cell 100 2000 391 398
80. E.C. Ferber, M. Kajita, A. Wadlow, L. Tobiansky, C. Niessen, H. Ariga, J. Daniel, and Y. Fujita A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus J. Biol. Chem. 283 2008 12691 12700
81. T. Maretzky, K. Reiss, A. Ludwig, J. Buchholz, F. Scholz, E. Proksch, B. de Strooper, D. Hartmann, and P. Saftig ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation Proc. Natl. Acad. Sci. U.S.A. 102 2005 9182 9187 (Pubitemid 40923538)
82. T. Maretzky, M. Schulte, A. Ludwig, S. Rose-john, C. Blobel, D. Hartmann, P. Altevogt, P. Saftig, and K. Reiss L1 is sequentially processed by Two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth Mol. Cell. Biol. 25 2005 9040 9053 (Pubitemid 41429092)
83. A. Stoeck, S. Keller, S. Riedle, M.P. Sanderson, S. Runz, F. Le Naour, P. Gutwein, A. Ludwig, E. Rubinstein, and P. Altevogt A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44 Biochem. J. 393 2006 609 618 (Pubitemid 43163801)
84. J.M. David, and A.K. Rajasekaran Dishonorable discharge: the oncogenic roles of cleaved e-cadherin fragments Cancer Res. 2012 2917 2923
85. T. Yamashita, A. Budhu, M. Forgues, and X.W. Wang Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma Cancer Res. 67 2007 10831 10839 (Pubitemid 350145912)
86. M.J. Winter, B. Nagelkerken, A.E. Mertens, H.A. Rees-Bakker, I.H. Briaire-de Bruijn, and S.V. Litvinov Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak Exp. Cell Res. 285 2003 50 58 (Pubitemid 36390155)
87. H. Kimura, H. Kato, A. Faried, M. Sohda, M. Nakajima, Y. Fukai, T. Miyazaki, N. Masuda, M. Fukuchi, and H. Kuwano Prognostic significance of EpCAM expression in human esophageal cancer Int. J. Oncol. 30 2007 171 179
88. S. Petsch, O. Gires, D. Rüttinger, S. Denzel, S. Lippold, P.A. Baeuerle, and A. Wolf Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110 mAbs 3 2011 31 37
89. S. Runz, S. Keller, C. Rupp, A. Stoeck, Y. Issa, D. Koensgen, A. Mustea, J. Sehouli, G. Kristiansen, and P. Altevogt Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM Gynecol. Oncol. 107 2007 563 571 (Pubitemid 350160873)
90. S. Denzel, D. Maetzel, B. Mack, C. Eggert, G. Bärr, and O. Gires Initial activation of EpCAM cleavage via cell-to-cell contact BMC Cancer 9 2009 402
91. F. Le Naour, M. André, C. Boucheix, and E. Rubinstein Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts Proteomics 6 2006 6447 6454 (Pubitemid 46048385)
92. M. Zöller Tetraspanins: push and pull in suppressing and promoting metastasis Nat. Rev. Cancer 9 2009 40 55
93. M.E. Hemler Tetraspanin functions and associated microdomains Nat. Rev. Mol. Cell Biol. 6 2005 801 811 (Pubitemid 41726118)
94. F. Le Naour, M. André, C. Greco, M. Billard, B. Sordat, J.-F. Emile, F. Lanza, C. Boucheix, and E. Rubinstein Profiling of the tetraspanin web of human colon cancer cells Mol. Cell. Proteomics 5 2006 845 857 (Pubitemid 43792794)
95. D.-S. Schmidt, P. Klingbeil, M. Schnölzer, and M. Zöller CD44 variant isoforms associate with tetraspanins and EpCAM Exp. Cell Res. 297 2004 329 347 (Pubitemid 38798397)
96. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion molecules to signalling regulators Nat. Rev. Mol. Cell Biol. 4 2003 33 45 (Pubitemid 36077255)
97. C. Claas, J. Wahl, D.J. Orlicky, H. Karaduman, M. Schnölzer, T. Kempf, and M. Zöller The tetraspanin D61A and its molecular partners on rat carcinoma cells Biochem. J. 389 2005 99 110 (Pubitemid 40978012)
98. M.M. Richardson, L.K. Jennings, and X.A. Zhang Tetraspanins and tumor progression Clin. Exp. Metastasis 28 2011 261 270
99. C. Boucheix, and E. Rubinstein Tetraspanins Cell. Mol. Life Sci. 58 2001 1189 1205 (Pubitemid 32844093)
100. M. Ladwein, U.-F. Pape, D.-S. Schmidt, M. Schnölzer, S. Fiedler, L. Langbein, W.W. Franke, G. Moldenhauer, and M. Zöller The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7 Exp. Cell Res. 309 2005 345 357 (Pubitemid 41317358)
101. S. Kuhn, M. Koch, T. Nübel, M. Ladwein, D. Antolovic, P. Klingbeil, D. Hildebrand, G. Moldenhauer, L. Langbein, W.W. Franke, J. Weitz, and M. Zöller A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression Mol. Cancer Res. 5 2007 553 567 (Pubitemid 46985046)
102. C. Arduise, T. Abache, L. Li, M. Billard, A. Chabanon, A. Ludwig, P. Mauduit, C. Boucheix, E. Rubinstein, and F. Le Naour Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor J. Immunol. 181 2008 7002 7013
103. P. Saftig, and K. Reiss The "a disintegrin and metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90 2011 527 535
104. J. Pruessmeyer, and A. Ludwig The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer Semin. Cell Dev. Biol. 20 2009 164 174
105. K. Reiss, and P. Saftig The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions Semin. Cell Dev. Biol. 20 2009 126 137
106. D. Xu, C. Sharma, and M.E. Hemler Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein FASEB J. 23 2009 3674 3681
107. M.D. Gutiérrez-López, A. Gilsanz, M. Yáñez- Mó, S. Ovalle, E.M. Lafuente, C. Domínguez, P.N. Monk, I. González-Alvaro, F. Sánchez-Madrid, and C. Cabañas The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9 Cell. Mol. Life Sci. 68 2011 3275 3292
108. A.L. Stone, M. Kroeger, and Q.X. Sang Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review) J. Protein Chem. 18 1999 447 465 (Pubitemid 29382098)
109. E. Tellier, M. Canault, L. Rebsomen, B. Bonardo, I. Juhan-Vague, G. Nalbone, and F. Peiretti The shedding activity of ADAM17 is sequestered in lipid rafts Exp. Cell Res. 312 2006 3969 3980 (Pubitemid 44828045)
110. M. Yáñez-Mó, M.D. Gutiérrez-López, and C. Cabañas Functional interplay between tetraspanins and proteases Cell. Mol. Life Sci. 68 2011 3323 3335
111. F. Momburg, G. Moldenhauer, and G.J. Hämmerling Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues Cancer Res. 47 1987 2883 2891 (Pubitemid 17113431)
112. P. Went, A. Lugli, S. Meier, M. Bundi, M. Mirchlacher, G. Sauter, and S. Dirnhofer Frequent EpCam protein expression in human carcinomas Hum. Pathol. 35 2004 122 128 (Pubitemid 38133932)
113. A. Nelson, R. Dunn, R. Peach, A. Aruffo, and A. Farr The murine homolog of human Ep-CAM, a homotypic adhesion molecule, is expressed by thymocytes and thymic epithelial cells Eur. J. Immunol. 26 1996 401 408 (Pubitemid 26060248)
114. T.A. Borkowski, A.J. Nelson, A.G. Farr, and M.C. Udey Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells Eur. J. Immunol. 26 1996 110 114 (Pubitemid 26028420)
115. N. Barker, J.H. van Es, J. Kuipers, P. Kujala, M. van den Born, M. Cozijnsen, A. Haegebarth, J. Korving, H. Begthel, P.J. Peters, and H. Clevers Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature 449 2007 1003 1007 (Pubitemid 350014593)
116. C.J. de Boer, J.H. van Krieken, C.M. Janssen-van Rhijn, and S.V. Litvinov Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver J. Pathol. 188 1999 201 206 (Pubitemid 29253941)
117. V. Cirulli, L. Crisa, G.M. Beattie, M.I. Mally, A.D. Lopez, A. Fannon, A. Ptasznik, L. Inverardi, C. Ricordi, T. Deerinck, M. Ellisman, R.A. Reisfeld, and A. Hayek KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development J. Cell Biol. 140 1998 1519 1534 (Pubitemid 28152999)
118. M. Sundberg, L. Jansson, J. Ketolainen, H. Pihlajamäki, R. Suuronen, H. Skottman, J. Inzunza, O. Hovatta, and S. Narkilahti CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells Stem Cell Res. 2 2009 113 124
119. V.Y. Ng, S.N. Ang, J.X. Chan, and A.B.H. Choo Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells Stem Cells 28 2010 29 35
120. T.Y. Lu, R.M. Lu, M.Y. Liao, J. Yu, C.H. Chung, C.F. Kao, and H.C. Wu Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells J. Biol. Chem. 285 2010 8719 8732
121. B. González, S. Denzel, B. Mack, M. Conrad, and O. Gires EpCAM is involved in maintenance of the murine embryonic stem cell phenotype Stem Cells 27 2009 1782 1791
122. H.P. Huang, P.H. Chen, C.Y. Yu, C.Y. Chuang, L. Stone, W.C. Hsiao, C.L. Li, S.C. Tsai, K.Y. Chen, H.F. Chen, H.N. Ho, and H.C. Kuo Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming J. Biol. Chem. 286 2011 33520 33532
123. K. Slanchev, T.J. Carney, M.P. Stemmler, B. Koschorz, A. Amsterdam, H. Schwarz, and M. Hammerschmidt The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development PLoS Genet. 5 2009 e1000563
124. K. Nagao, J. Zhu, M.B. Heneghan, J.C. Hanson, M.I. Morasso, L. Tessarollo, S. Mackem, and M.C. Udey Abnormal placental development and early embryonic lethality in EpCAM-null mice PLoS One 4 2009 e8543
125. E. Guerra, R. Lattanzio, R. La Sorda, F. Dini, G.M. Tiboni, M. Piantelli, and S. Alberti mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin PLoS One 7 2012 e49302
126. U. Schnell, J. Kuipers, J.L. Mueller, A. Veenstra-Algra, M. Sivagnanam, and B.N.G. Giepmans Absense of cell surface EpCAM in congenital tufting enteropathy Hum. Mol. Genet. 2013 10.1093/hmg/ddt105 (publ. ahead of print)
127. D.B. Seligson Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma Clin. Cancer Res. 10 2004 2659 2669 (Pubitemid 38509139)
128. R. Ralhan, J. Cao, T. Lim, C. Macmillan, J.L. Freeman, and P.G. Walfish EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis BMC Cancer 10 2010 331
129. B.T.F. van der Gun, L.J. Melchers, M.H.J. Ruiters, L.F.M.H. de Leij, P.M.J. McLaughlin, and M.G. Rots EpCAM in carcinogenesis: the good, the bad or the ugly Carcinogenesis 31 2010 1913 1921
130. C. Patriarca, R.M. Macchi, A.K. Marschner, and H. Mellstedt Epithelial cell adhesion molecule expression (CD326) in cancer: a short review Cancer Treat. Rev. 38 2012 68 75
131. L.J. Melchers, L. Bruine de Bruin, U. Schnell, L. Slagter-Menkema, G. De Bock, B. Van Dijk, B.N.G. Giepmans, B. Van der Laan, J. Van der Wal, J. Roodenburg, and E. Schuuring Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma 2013 (under review)
132. R. Ralhan, H.C.-H. He, A.K.-C. So, S.C. Tripathi, M. Kumar, M.R. Hasan, J. Kaur, L. Kashat, C. MacMillan, S.S. Chauhan, J.L. Freeman, and P.G. Walfish Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers PLoS One 5 2010 e14130
133. T. Kunavisarut, I. Kak, C. Macmillan, R. Ralhan, and P.G. Walfish Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma BMC Cancer 12 2012 523
134. U. Schnell, F. Dijk, K.A. Sjollema, and B.N.G. Giepmans Immunolabeling artifacts and the need for live-cell imaging Nat. Methods 9 2012 152 158
135. R. Riesenberg, A. Buchner, H. Pohla, and H. Lindhofer Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM × alpha CD3) J. Histochem. Cytochem. 49 2001 911 917 (Pubitemid 32565984)
136. S. Mosolits, K. Markovic, J.-E. Frödin, L. Virving, C.G.M. Magnusson, M. Steinitz, J. Fagerberg, and H. Mellstedt Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients Clin. Cancer Res. 10 2004 5391 5402 (Pubitemid 39100476)
137. E. Bremer, D. Samplonius, B.-J. Kroesen, L. van Genne, L. de Leij, and W. Helfrich Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells Neoplasia 6 2004 636 645 (Pubitemid 39411100)
138. E. Bremer, J. Kuijlen, D. Samplonius, H. Walczak, L. de Leij, and W. Helfrich Target cell-restricted and -enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma-associated antigen EGP2 Int. J. Cancer 109 2004 281 290 (Pubitemid 38240933)
139. C. Di Paolo, J. Willuda, S. Kubetzko, I. Lauffer, D. Tschudi, R. Waibel, A. Plueckthun, R.A. Stahel, and U. Zangenmeister-Wittke A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity Clin. Cancer Res. 9 2003 2837 2848 (Pubitemid 36842130)
140. K. Flatmark, I.J. Guldvik, H. Svensson, K.G. Fleten, V.A. Flørenes, W. Reed, K.E. Giercksky, O. Fodstad, and Y. Andersson Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies Int. J. Cancer 2013 10.1002/ijc.28158 (Epub ahead of print)
141. R.P. Kuiper, L.E.L.M. Vissers, R. Venkatachalam, D. Bodmer, E. Hoenselaar, M. Goossens, A. Haufe, E. Kamping, R.C. Niessen, F.B.L. Hogervorst, J.J.P. Gille, B. Redeker, C.M.J. Tops, M.E. van Gijn, A.M.W. van den Ouweland, N. Rahner, V. Steinke, P. Kahl, E. Holinski-Feder, M. Morak, M. Kloor, M.S. Stemmler, B. Betz, P. Hutter, D.J. Bunyan, S. Syngal, J.O. Culver, T. Graham, T.L. Chan, I.D. Nagtegaal, J.H. van Krieken, H.K. Schackert, N. Hoogerbrugge, A.G. van Kessel, and M.J. Ligtenberg Recurrence and variability of germline EPCAM deletions in Lynch syndrome Hum. Mutat. 32 2011 407 414
142. M.J.E. Kempers, R.P. Kuiper, C.W. Ockeloen, P.O. Chappuis, P. Hutter, N. Rahner, H.K. Schackert, V. Steinke, E. Holinski-Feder, M. Morak, M. Kloor, R. Büttner, E.T.P. Verwiel, J.H. van Krieken, I.D. Nagtegaal, M. Goossens, R.S. van der Post, R.C. Niessen, R.H. Sijmons, I. Kluijt, F.B. Hogervorst, E.M. Leter, J.J. Gille, C.M. Aalfs, E.J. Redeker, F.J. Hes, C.M. Tops, B.P. van Nesselrooij, M.E. van Gijn, E.B. Gómez García, D.M. Eccles, D.J. Bunyan, S. Syngal, E.M. Stoffel, J.O. Culver, M.R. Palomares, T. Graham, L. Velsher, J. Papp, E. Oláh, T.L. Chan, S.Y. Leung, A.G. van Kessel, L.A. Kiemeney, N. Hoogerbrugge, and M.J. Ligtenberg Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study Lancet Oncol. 12 2011 49 55
143. M.J.L. Ligtenberg, R.P. Kuiper, T.L. Chan, M. Goossens, K.M. Hebeda, M. Voorendt, T.Y.H. Lee, D. Bodmer, E. Hoenselaar, S.J.B. Hendriks-Cornelissen, W.Y. Tsui, C.K. Kong, H.G. Brunner, A.G. van Kessel, S.T. Yuen, J.H.J.M. van Krieken, S.Y. Leung, and N. Hoogerbrugge Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 Nat. Genet. 41 2009 112 117
144. K. Rumilla, K.V. Schowalter, N.M. Lindor, B.C. Thomas, K.A. Mensink, S. Gallinger, S. Holter, P.A. Newcomb, J.D. Potter, M.A. Jenkins, J.L. Hopper, T.I. Long, D.J. Weisenberger, R.W. Haile, G. Casey, P.W. Laird, L. Le Marchand, and S.N. Thibodeau Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases J. Mol. Diagn. 13 2011 93 99
145. H.T. Lynch, J.F. Lynch, C.L. Snyder, and D. Riegert-Johnson EPCAM deletions, Lynch syndrome, and cancer risk Lancet Oncol. 12 2011 5 6
146. M. Kloor, A.Y. Voigt, H.K. Schackert, P. Schirmacher, M. von Knebel Doeberitz, and H. Bläker Analysis of EPCAM protein expression in diagnostics of Lynch syndrome J. Clin. Oncol. 29 2011 223 227
147. C. Huth, M. Kloor, A.Y. Voigt, G. Bozukova, C. Evers, H. Gaspar, M. Tariverdian, P. Schirmacher, M. von Knebel Doeberitz, and H. Bläker The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors Mod. Pathol. 25 2012 911 916
148. O. Goulet, J. Salomon, F. Ruemmele, N.P.-M. de Serres, and N. Brousse Intestinal epithelial dysplasia (tufting enteropathy) Orphanet J. Rare Dis. 2 2007 20
149. R. Reifen, E. Cutz, and A. Griffiths Tufting enteropathy: a newly recognized clinicopathological entity associated with refractory diarrhea in infants J. Pediatr. Gastroenterol. Nutr. 18 1994 379 385 (Pubitemid 24125854)
150. M. Sivagnanam, T. Schaible, R. Szigeti, R.H. Byrd, M.J. Finegold, S. Ranganathan, G.S. Gopalakrishna, N. Tatevian, and R. Kellermayer Further evidence for EpCAM as the gene for congenital tufting enteropathy Am. J. Med. Genet. A 152A 2010 222 224
151. S.M. Al-Mayouf, N. Alswaied, F.S. Alkuraya, A. Almehaidib, and M. Faqih Case report tufting enteropathy and chronic arthritis: a newly recognized association with a novel EpCAM gene mutation J. Pediatr. 49 2009 642 644
152. J.S. Ko, J.K. Seo, J.O. Shim, S.H. Hwang, H.S. Park, and G.H. Kang Tufting enteropathy with EpCAM mutations in two siblings Gut Liver 4 2010 407 410
153. J. Salomon, Y. Espinosa-Parrilla, O. Goulet, W. Al-Qabandi, P. Guigue, D. Canioni, J. Bruneau, F. Alzahrani, S. Almuhsen, N. Cerf-Bensussan, M. Jeanpierre, N. Brousse, S. Lyonnet, A. Munnich, and A. Smahi A founder effect at the EPCAM locus in congenital tufting enteropathy in the Arabic Gulf Eur. J. Med. Genet. 54 2011 319 322
154. L.M. Bird, M. Sivagnanam, S. Taylor, and R.O. Newbury A new syndrome of tufting enteropathy and choanal atresia, with ophthalmologic, hematologic and hair abnormalities Clin. Dysmorphol. 16 2007 211 221 (Pubitemid 47360226)
155. O. Roche, M. Putterman, J. Salomon, F. Lacaille, N. Brousse, O. Goulet, and J.L. Dufier Superficial punctate keratitis and conjunctival erosions associated with congenital tufting enteropathy Am. J. Ophthalmol. 150 2010 116 121
156. M. Sivagnanam, A.R. Janecke, T. Müller, P. Heinz-Erian, S. Taylor, and L.M. Bird Case of syndromic tufting enteropathy harbors SPINT2 mutation seen in congenital sodium diarrhea Clin. Dysmorphol. 19 2010 48
157. N.V. Sankpal, M.W. Willman, T.P. Fleming, J.D. Mayfield, and W.E. Gillanders Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion Cancer Res. 69 2009 753 757
158. M. Pavšič, and B. Lenarčič Expression, crystallization and preliminary X-ray characterization of the human epithelial cell-adhesion molecule ectodomain Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67 2011 1363 1366